Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 23:12:784130.
doi: 10.3389/fcimb.2022.784130. eCollection 2022.

Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic

Samaneh Pourajam  1 , Elham Kalantari  2 , Hamid Talebzadeh  3 , Hamid Mellali  3 , Ramin Sami  1 , Forogh Soltaninejad  4 , Babak Amra  5 , Mahdi Sajadi  6 , Malihe Alenaseri  7 , Forough Kalantari  8 , Hamid Solgi  6   9
Affiliations

Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic

Samaneh Pourajam et al. Front Cell Infect Microbiol. .

Abstract

Data on the prevalence of bacterial co-infections and secondary infection among adults with COVID-19 admitted to the intensive care unit (ICU) are rare. We aimed to determine the frequency of secondary bacterial infection, antibiotic use, and clinical characteristics in patients admitted to the ICU with severe SARS-CoV-2 pneumonia. This was a retrospective cohort study of adults with severe COVID-19 admitted to two ICUs from March 6 to September 7, 2020 in an academic medical center in Isfahan, Iran. To detect COVID-19, reverse transcription real-time polymerase chain reaction was performed and also typical pattern of CT scan was used for the diagnosis of COVID-19. Data collection included the age, gender, main symptoms, history of underlying disease, demographics, hospital stay, outcomes, and antibiotic regimen of the patient. Antimicrobial susceptibility testing was carried out according to the CLSI guidelines. During the study period, 553 patients were referred to the both ICUs for COVID-19 with severe pneumonia. Secondary bacterial infection was detected in 65 (11.9%) patients. The median age was 69.4 (range 21-95) years; 42 (63.6%) were men. Notably, 100% (n = 65) of the patients with superinfection were prescribed empirical antibiotics before first positive culture, predominantly meropenem (86.2%) with a median duration of 12 (range 2-32) days and levofloxacin (73.8%) with a median duration of nine (range 2-24) days. Most prevalent causative agents for secondary bacterial infection were Klebsiella pneumoniae (n = 44) and Acinetobacter baumannii (n = 33). Most patients with secondary bacterial infection showed extensive drug-resistance. The mortality among patients who acquired superinfections was 83% against an overall mortality of 38.1% in total admitted COVID-19 patients. We found a high prevalence of carbapenem-resistant Gram-negative bacilli in COVID-19 patients admitted to our ICUs, with a high proportion of K. pneumoniae followed by A. baumannii. These findings emphasize the importance of implementation of strict infection control measures and highlight the role of antimicrobial stewardship during a pandemic.

Keywords: COVID-19; antibiotic use; bacterial co-infection; carbapenem resistant bacteria; intensive care unit.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Arayasukawat P., So−Ngern A., Reechaipichitkul W., Chumpangern W., Arunsurat I., Ratanawatkul P., et al. (2012). Microorganisms and Clinical Outcomes of Early- and Late-Onset Ventilator-Associated Pneumonia at Srinagarind Hospital, a Tertiary Center in Northeastern Thailand. BMC Pulm Med. 21, 1–8. doi: 10.1186/s12890-021-01415-8 - DOI - PMC - PubMed
    1. Balkhair A., Al-Muharrmi Z., Al’adawi B., Al Busaidi I., Taher H. B., AL-Siyabi T., et al. (2019). Prevalence and 30-Day All-Cause Mortality of Carbapenem-and Colistin-Resistant Bacteraemia Caused by Acinetobacter Baumannii, Pseudomonas Aeruginosa, and Klebsiella Pneumoniae: Description of a Decade-Long Trend. Int. J. Infect. Dis. 85, 10–15. doi: 10.1016/j.ijid.2019.05.004 - DOI - PubMed
    1. Baskaran V., Lawrence H., Elansbury L., Webb K., Safavi S., Zainuddin N., et al. (2021). Co-Infection in Critically Ill Patients With COVID-19: An Observational Cohort Study From England. J. Med. Microb. 70, 1–9. doi: 10.1099/jmm.0.001350 - DOI - PMC - PubMed
    1. Bolourchi N., Shahcheraghi F., Giske C. G., Nematzadeh S., Noori Goodarzi N., Solgi H., et al. (2021). Comparative Genome Analysis of Colistin-Resistant OXA-48-Producing Klebsiella Pneumoniae Clinical Strains Isolated From Two Iranian Hospitals. Ann. Clin. Microbiol. Antimicrob. 74, 1–11. doi: 10.1186/s12941-021-00479-y - DOI - PMC - PubMed
    1. Clinical and Laboratory Standards Institute [CLSI] (2017). Performance Standards for Antimicrobial Susceptibility Testing. 27th Edn (Wayne, PA: Clinical and Laboratory Standards Institute; ).

Publication types